Trends in antifungal susceptibility testing using CLSI reference and commercial methods (Q37557695)

21 August 2017

1 reference

title

Trends in antifungal susceptibility testing using CLSI reference and commercial methods (English)

1 reference

21 August 2017

2

Ana Espinel-Ingroff

1 reference

21 August 2017

Emilia Cantón

1

1 reference

PubMed ID

19622060

21 August 2017

Javier Pemán

series ordinal

3

1 reference

21 August 2017

1 February 2009

1 reference

Expert Review of Anti-infective Therapy

21 August 2017

1 reference

21 August 2017

7

1 reference

21 August 2017

1

1 reference

21 August 2017

107-119

1 reference

Caspofungin disk diffusion breakpoints and quality control

21 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Acquired resistance to echinocandins in Candida albicans: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Has antifungal susceptibility testing come of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Quality control parameters for broth microdilution tests of anidulafungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Quality control limits for posaconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.107

21 January 2018

Identifiers

DOI

10.1586/14787210.7.1.107

1 reference

21 August 2017

1 reference

PubMed ID

19622060